A phase II study of the survivin suppressant YM155 in patients with refractory diffuse large B-cell lymphoma

Bruce D. Cheson, Nancy L. Bartlett, Julie M. Vose, Andres Lopez-Hernandez, Amanda L. Seiz, Anne T. Keating, Setareh Shamsili

Research output: Contribution to journalArticlepeer-review

98 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II study of the survivin suppressant YM155 in patients with refractory diffuse large B-cell lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences